Expert Opin Drug Discov
Dr. Prithviraj Bose, MD
- Medicare services, 2024
- 760
- Medicare patients, 2024
- 187
- Part D claims, 2024
- 147
- Publications
- 187
- Clinical trials
- 3
- Practice address
- 1515 Holcombe Blvd, Houston, TX 77030
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Bose's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Prithviraj Bose is a hematologist and oncologist in Houston, Texas
Dr. Bose practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.
Dr. Bose's NPI, 1154449114, was assigned on March 27, 2007. Dr. Bose graduated from Medical College and Hospital Kolkata in 2002. Dr. Bose's Virginia license number on file is 0101246281.
- NPI
- 1154449114NPI Registry (opens in a new tab)
- Medicare PAC ID
- 5597880112
- NPI enumeration date
- March 27, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 51
- Medical school graduation
- 2002
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Prithviraj Bose practices at The University of Texas MD Anderson Cancer Center in Houston, Texas
Dr. Bose's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.
- The University of Texas MD Anderson Cancer Center1515 Holcombe Blvd, Houston, TX 77030
Source: Dmand AI Affiliation Data
Dr. Prithviraj Bose is affiliated with 1 site of care and 1 medical group
Dr. Bose's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Prithviraj Bose's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bose practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| The University of Texas MD Anderson Cancer Center | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across The University of Texas System and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Prithviraj Bose is one of 814 hematologists and oncologists in Texas
Hematology and oncology is Dr. Bose's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bose is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Bose's licenses on file in 12 states: Virginia, Florida, Arizona, Tennessee, Washington, Georgia, Louisiana, Texas, Alabama, Mississippi, Oklahoma and Michigan.
Specialties and state licenses
- Hematology and oncology, VirginiaPrimary
- Florida license
- Arizona license
- Tennessee license
- Washington license
- Georgia license
- Louisiana license
- Texas license
- Alabama license
- Mississippi license
- Oklahoma license
- Internal medicine, Michigan
Clinical focus
Dmand AI lists anemia, chronic anemia, chronic leukemia, lung cancer, lymphoma and prostate cancer among the conditions Dr. Bose treats.
Hematologists and oncologists near Dr. Bose
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Prithviraj Bose billed Medicare for 760 services in 2024
CMS data shows 760 Medicare services from Dr. Bose across 7 procedure codes in 2024, for 187 Medicare patients. Medicare paid $63,881 for them.
Dr. Bose's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 8082024: 7606%
Where Dr. Bose's Medicare services took place, 2024
- In an office203%
- In a facility74097%
Dr. Bose compared with the Texas median for hematologists and oncologists, 2024
- Dr. Bose
- Texas median
- Medicare services
- 760vs 1,16235% below
- Medicare patients
- 187vs 25125% below
- Part D claims
- 49vs 48990% below
Medians across 758 hematologists and oncologists in Texas with Dmand AI profiles that report each measure.
Dr. Bose's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Bose?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Bose and other hematologists and oncologists in Texas.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Prithviraj Bose treated 187 Medicare patients in 2024, average age 74
CMS counts 187 Medicare patients who saw Dr. Bose in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have high blood pressure, and 72% have high cholesterol. Their average risk score is 2.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Bose's median patient age at 72, with 49% women.
Dr. Bose's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Bose's Medicare patients by sex, 2024
- Women8847%
- Men9953%
Chronic conditions among Dr. Bose's Medicare patients, 2024
- High blood pressure75%
- High cholesterol72%
- Arthritis44%
- Chronic kidney disease40%
- Ischemic heart disease35%
- Diabetes32%
- Mood disorders32%
- Anxiety28%
Share of Medicare patients with each condition. A patient can have several.
Dr. Bose's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women49%
- Men51%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Prithviraj Bose wrote 147 Medicare Part D claims in 2024
In 2024, Dr. Bose wrote 147 Medicare Part D claims for 44 patients. 77% of them were for generic drugs. CMS names the drug for 49 of them, across 3 drugs with 11 or more claims each, at $342,948 in total drug cost. In 2023, CMS named 66 claims across 4 drugs.
Dr. Bose's Part D claims by kind of drug, 2024
- Generic113 claims77%
- Brand-name34 claims23%
Dr. Bose's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Bose's Part D claims, 2024
- Antibiotics14%21 of 147 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 662024: 4926%
Drugs named by CMS: 3 in 2024, 4 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Prithviraj Bose scored 84 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Bose for performance year 2024, reported as part of a group. Dr. Bose accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bose as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Bose's MIPS scores, performance year 2024
- 84of 100Final score
- 70.8of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 68of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Prithviraj Bose has 187 publications on record
Dmand AI links 187 papers to Dr. Bose, published from 2009 to 2025. 2021 was the busiest year, with 18. The most frequent topics are Primary Myelofibrosis, Leukemia, Myeloid, Acute and Protein Kinase Inhibitors. Dr. Bose has published most often in Clin Lymphoma Myeloma Leuk. Dr. Bose's most frequent co-authors are Naveen Pemmaraju, MD, Srdan Verstovsek, MD, PhD and Hagop M. Kantarjian, MD.
Dr. Bose's papers by year, 2016 to 2025
Topics Dr. Bose writes about most
- Primary Myelofibrosis
- Leukemia, Myeloid, Acute
- Protein Kinase Inhibitors
- Antineoplastic Combined Chemotherapy Protocols
- Pyrimidines
- Nitriles
- Pyrazoles
- Antineoplastic Agents
Dr. Bose's most frequent co-authors
- Naveen Pemmaraju, MD54 shared papers
- Srdan Verstovsek, MD, PhD54 shared papers
- Hagop M. Kantarjian, MD50 shared papers
Recent publications by Dr. Bose
Curr Hematol Malig Rep
Nat Rev Dis Primers
See who Dr. Bose researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Bose works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Prithviraj Bose has worked on 3 clinical trials
Dmand AI links Dr. Bose to 3 clinical trials. Conditions studied include Agranulocytosis, Leukemia, Myeloid, Accelerated Phase and Leukemia, Myeloid, Acute. M.D. Anderson Cancer Center sponsors the most, 2.
Clinical trials with Dr. Bose by phase
- 1Phase 1: 1 trial
- 1Phase 2: 1 trial
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Bose's trials
- Agranulocytosis
- Leukemia, Myeloid, Accelerated Phase
- Leukemia, Myeloid, Acute
- Blast Crisis
- Leukemia, Myeloid
Investigators on the most trials with Dr. Bose
- Jessica Kaplan Altman, MD1 shared trial
- Dale Lee Bixby, MD1 shared trial
- Daniel Joseph Deangelo, MD, PhD1 shared trial
Recent clinical trials with Dr. Bose
Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid Leukemia (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Prithviraj Bose received $494,199 in industry payments from 2016 to 2025
CMS Open Payments shows 464 general payments to Dr. Bose from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. Incyte Corporation paid the most, $198,766. It also lists 4 research payments totaling $3,518 in 2025.
General payments to Dr. Bose by program year, 2016 to 2025
General payments to Dr. Bose by kind, 2016 to 2025
- Consulting fees$345,65770%
- Speaker and faculty fees$60,17012%
- Travel and lodging$46,1789%
- Honoraria$25,7005%
- Other$16,4003%
Companies that paid Dr. Bose the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Prithviraj Bose has 4 awards and honors on record
Dmand AI lists 4 awards for Dr. Bose, most recently Physician’s Recognition Award with Commendation in 2011.
Awards and honors for Dr. Bose
- 2011
- Physician’s Recognition Award with Commendation
- 1997
- University Honors
- 1995
- First Certificate of Honors in Biochemistry
- Undated
- Outstanding Researcher
Source: Dmand AI Professional Profile Data
Dr. Prithviraj Bose graduated from Medical College and Hospital Kolkata
Dr. Bose graduated from Medical College and Hospital Kolkata in 2002. Dr. Bose is a member of ASCO.
- Medical school
- Board certified in hematology
Source: Dmand AI Professional Profile Data
Dr. Prithviraj Bose accepts plans from 6 insurance carriers
Dr. Bose is in network with 6 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.
- Aetna
- Elevance
- Excellus BlueCross BlueShield
- Blue Cross Blue Shield of Michigan
- Blue Cross Blue Shield of Massachusetts
- CMS Medicare
Plan types Dr. Bose accepts, by number of carriers
- Medicare5
- PPO5
- HMO4
- POS4
- EPO3
Source: Dmand AI Insurance Network Data
Sources for Dr. Prithviraj Bose's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Prithviraj Bose
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Prithviraj Bose's NPI number?
Dr. Prithviraj Bose's NPI number is 1154449114. It was assigned on March 27, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Prithviraj Bose?
Dr. Prithviraj Bose is a hematologist and oncologist in Houston, Texas. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Prithviraj Bose practice?
Dr. Bose practices at 1515 Holcombe Blvd, Houston, TX 77030. Dr. Bose's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.
What is Dr. Prithviraj Bose's medical license number?
Dr. Bose's Virginia license number on file is 0101246281, one of the licenses on file in 12 states.
Which states has Dr. Prithviraj Bose been licensed in?
Dmand AI has state licenses on file for Dr. Bose in Virginia (2009 to 2016), Florida (since 2021), Arizona (2022 to 2027), Tennessee (2022 to 2027), Washington (2022 to 2027), Georgia (2022 to 2026), Louisiana (2022 to 2026), Texas (2015 to 2026), Alabama (2023 to 2025), Mississippi (2022 to 2025), Oklahoma (2007 to 2025) and Michigan (2005 to 2007).
Which hospitals is Dr. Prithviraj Bose affiliated with?
Dr. Bose practices at The University of Texas MD Anderson Cancer Center in Houston, Texas.
What medical group is Dr. Prithviraj Bose part of?
Dr. Bose is linked to Physicians Referral Service.
Does Dr. Prithviraj Bose accept Medicare?
Yes. CMS data shows Dr. Bose billed Medicare for 760 services in 2024, and Dr. Bose accepts Medicare assignment.
Does Dr. Prithviraj Bose offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Bose as offering telehealth services.
What is Dr. Prithviraj Bose's MIPS score?
Dr. Bose's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.
Show 10 more questionsShow fewer questions
How many Medicare patients does Dr. Prithviraj Bose see?
CMS counts 187 Medicare patients who saw Dr. Bose in 2024, with an average age of 74.
Is Dr. Prithviraj Bose board certified?
Yes. Dr. Bose is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. Prithviraj Bose bill to Medicare?
In 2024, Dr. Bose's most billed Medicare services were office visit, established patient (99214), hospital inpatient care (99233) and office visit, established patient (99215).
Where did Dr. Prithviraj Bose go to medical school?
Dr. Bose graduated from Medical College and Hospital Kolkata in 2002.
What drugs does Dr. Prithviraj Bose prescribe most?
In 2024 Medicare Part D data, Dr. Bose's most prescribed drugs by claims were Jakafi, Valacyclovir and Levofloxacin.
Has Dr. Prithviraj Bose received payments from drug or device companies?
CMS Open Payments shows $494,199 in general payments to Dr. Bose from 24 companies from 2016 to 2025. The largest total came from Incyte Corporation.
How long has Dr. Prithviraj Bose been practicing?
Dr. Bose graduated from medical school in 2002, 24 years ago.
Does Dr. Prithviraj Bose do research?
Dmand AI links 187 publications to Dr. Bose, published from 2009 to 2025. Dr. Bose has worked on 3 clinical trials.
Who does Dr. Prithviraj Bose publish with?
Dr. Bose's most frequent co-authors are Naveen Pemmaraju, MD (54 shared papers), Srdan Verstovsek, MD, PhD (54 shared papers) and Hagop M. Kantarjian, MD (50 shared papers).
What insurance does Dr. Prithviraj Bose accept?
Dr. Bose is in network with 6 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in Texas by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card